Tranilast in the Therapy of Coronary Artery Disease.

作者
Radha Gopalan,S Goldberg
出处
期刊:PubMed [National Institutes of Health]
卷期号:2 (2): 149-156 被引量:4
链接
标识
摘要

Restenosis after percutaneous intervention remains a significant clinical problem. Although stent implantation has significantly reduced the rate of restenosis by approximately 25% to 33%, intimal hyperplasia within stents still limits long-term vessel patency. The clinical sequelea of this neointimal proliferation is more pronounced in certain patient subgroups, eg, patients with diatbetes mellitus, diffuse disease, smaller vessels, chronic total occlusions, and lesions located in saphenous vein bypass grafts. Pharmacologic agents studied to date have failed to prevent restenosis. Tranilast, a novel anti-inflammatory agent, interferes with the proliferation and migration of vascular smooth muscle cells (VSMCs) induced by platelet-derived growth factor and transforming growth factor beta-1. Basic and preliminary clinical studies conducted with tranilast in Japan have shown encouraging results in terms of reducing restenosis. The Prevention of Restenosis with Tranilast and its Outcomes study (PRESTO), a double-blind, placebo-controlled study (n = 11,500), will test the efficacy of two doses (300 and 450 mg twice a day) of tranilast administered for 1 and 3 months compared with placebo. The primary objective is to compare the composite clinical event rate (death, myocardial infarction, or the need for ischemia-driven target vessel revascularization) after 9 months in patients treated with tranilast or placebo. Angiographic and intravascular ultrasound studies will be peformed in order to assess the effects of tranilast on angiographic restenosis and the volume of intimal hyperplastic tissue. If successful, tranilast will be the first drug to reduce angiographic and clinical restenosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
水煮电吹风的应助被叉叉采纳,获得10
1秒前
2秒前
wzg666完成签到,获得积分10
2秒前
唐鑫完成签到,获得积分10
2秒前
GVD完成签到,获得积分10
3秒前
3秒前
英吉利25发布了新的文献求助10
3秒前
4秒前
4秒前
5秒前
5秒前
愿抒发布了新的文献求助10
5秒前
5秒前
小二郎的应助被和谐如风采纳,获得10
8秒前
8秒前
FashionBoy的应助被科研究极进化采纳,获得10
8秒前
Limerence完成签到,获得积分10
8秒前
9秒前
研友_xLOMQZ发布了新的文献求助30
9秒前
zzzz发布了新的文献求助10
10秒前
李爱国的应助被zww113采纳,获得10
10秒前
丹亦发布了新的文献求助10
10秒前
bkagyin的应助被kgy采纳,获得10
11秒前
12秒前
Sunyidan完成签到,获得积分10
12秒前
小蘑菇的应助被elara采纳,获得10
12秒前
13秒前
ajiang完成签到,获得积分10
14秒前
Mottri完成签到,获得积分10
16秒前
零度完成签到,获得积分10
16秒前
17秒前
清辉影的应助被漫漫采纳,获得10
17秒前
炫彩小陈发布了新的文献求助10
17秒前
lxl完成签到,获得积分10
18秒前
18秒前
咕咕嘎嘎完成签到,获得积分10
19秒前
漫漫完成签到,获得积分10
19秒前
20秒前
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181888
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818887
捐赠科研通 7778145
什么是DOI,文献DOI怎么找? 3433528
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621